CXCR4 and acute myeloid leukemia: By analyzing the CXCR4 expression in each AML subtype, our results showed that the CXCR4 expression in patients with AML M4/M5 subtype was higher than any other subtypes, with significant statistical difference (P = .001; Figure 3A).